HRSA loan repayment program aims to boost opioid treatment access

Jan 07, 2019 - 02:49 PM
HRSA loan repayment program aims to boost opioid treatment access

The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance in exchange for their service on the front lines of the opioid crisis in underserved communities. The National Health Service Corps Substance Use Disorder Workforce Loan Repayment Program will boost access to preventive, treatment and recovery services for those struggling with substance use disorder, according to HRSA. Clinicians accepted to the program may receive up to $75,000 for three years of full-time service at a health care facility that has been designated by HRSA as an NHSC-approved substance use disorder site. A part-time service option also is available. Applications are due Feb. 21. 
 

Related News Articles

Headline
Gallup: Adult uninsured rate climbs to 13.7 percent
The share of U.S. adults without health insurance rose 1.5 percentage point between fourth-quarter 2017 and fourth-quarter 2018 to 13.7 percent.
Headline
NASEM workshop Feb. 4 on opioid prescribing guidelines for acute pain
The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain…
Headline
CMS approves Ariz. Medicaid waiver with work requirement
The Centers for Medicare…
Perspective
Perspective: Turning the Tide on the Prescription Drug Spending Crisis
Last week, I shared a few areas where we can advance health in America this year, even in a divided Congress.
Headline
FDA takes steps to spur OTC versions of naloxone
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
CDC: Rural patients more likely to receive opioid prescription
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…